Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.

World journal of gastroenterology - 21 Feb 2015

Nam Young-Sun, Kim Nayoun, Im Keon-Il, Lim Jung-Yeon, Lee Eun-Sol, Cho Seok-Goo

Abstract excerpt

AIM: To investigate the effects of mesenchymal stem cells (MSCs) on dextran sulfate sodium-induced inflammatory bowel disease (IBD). METHODS: C57BL/6 mice were fed 3.5% (g/L) dextran sulfate sodium. On day seven, the mice received intraperitoneal injections of 1×10(6) MSCs. The survival rate, disease activity index values, and body weight, were monitored daily. On day ten, colon lengths and histopathologic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colitis
Share to Colon
Share to Dextran Sulfate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation Mediators

Share to Mesenchymal Stem Cell Transplantation

Share to Mesenchymal Stem Cells

Share to Severity of Illness Index

Share to T-Lymphocytes

Source

Open in PubMed Open full text

Identifiers

PMID: 25717235
DOI: 10.3748/wjg.v21.i7.2030
PMCID: PMC4326137

Genes

MSC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.PMID 25717235Read ↗

Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease.Semantic proximity Read ↗

Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases.Semantic proximity Read ↗

Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis.Semantic proximity Read ↗

Modulation of nuclear factor-κB-mediated pro-inflammatory response is associated with exogenous administration of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis.Semantic proximity Read ↗

Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes.Semantic proximity Read ↗

Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.Semantic proximity Read ↗

Extracellular Vesicles Secreted by Mesenchymal Stromal Cells Exert Opposite Effects to Their Cells of Origin in Murine Sodium Dextran Sulfate-Induced Colitis.Semantic proximity Read ↗

Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease.Semantic proximity Read ↗

Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology.Semantic proximity Read ↗

Stem Cell-Based Therapies for Inflammatory Bowel DiseaseSemantic proximity Read ↗

Cancer-Preventive Role of Bone Marrow-Derived Mesenchymal Stem Cells on Colitis-Associated Colorectal Cancer: Roles of Gut Microbiota InvolvedSemantic proximity Read ↗

Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.